In a world of rapidly evolving diabetes technology, devices and medications, the Mary & Dick Allen Diabetes Center stays at the forefront of therapeutic advances by participating in clinical trials. These studies provide patients access to the latest leading-edge therapies.
Recent and current clinical trials include studies that investigate:
- Medication to delay the progression of newly diagnosed type 1 diabetes
- Continuous glucose monitoring device for patients with type 1 and type 2 diabetes
- Insulin pump and glucose sensor automation for patients with type 2 diabetes
- A novel component of an insulin pump for patients with type 1 diabetes
Clinical trials can range anywhere from a single visit to several years, and the sponsor of the trial often covers the costs of the clinical research and may even compensate volunteers.
“The FDA-approved treatments we have today are only available because someone in the past volunteered to participate in a clinical study. Participating in these studies for diabetes allow us to expand our knowledge and ability to manage a condition that affects so many people in our community,” said endocrinologist David Ahn, M.D., the Dr. Kris V. Iyer Endowed Chair in Diabetes Care and chief of diabetes services at Hoag.
If you’d like to learn more about clinical trials at the Mary & Dick Allen Diabetes Center, visit hoag.org/ClinicalTrials.
